Ignite Creation Date:
2025-12-25 @ 1:06 AM
Ignite Modification Date:
2026-03-05 @ 8:50 AM
Study NCT ID:
NCT02113293
Status:
COMPLETED
Last Update Posted:
2014-05-20
First Post:
2014-04-07
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
CyclASol® Phase 1 Study
Sponsor:
Novaliq GmbH
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
CYS-001
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None